Literature DB >> 30853681

Impact of Renal Dysfunction on Left Atrial Low-Voltage Areas in Patients With Atrial Fibrillation.

Yasuhiro Matsuda1, Masaharu Masuda1, Mitsutoshi Asai1, Osamu Iida1, Shin Okamoto1, Takayuki Ishihara1, Kiyonori Nanto1, Takashi Kanda1, Takuya Tsujimura1, Shota Okuno1, Aki Tsuji1, Toshiaki Mano1.   

Abstract

BACKGROUND: The presence of residual left atrial low-voltage areas (LVA) has been shown to be strongly associated with atrial fibrillation (AF) recurrence after pulmonary vein isolation. A preliminary study showed that concomitant chronic kidney disease (CKD) increased the rate of AF recurrence. The association between CKD and LVA, however, has not been elucidated. In the present study, we investigated the association between CKD severity and LVA prevalence. Methods and 
Results: In total, 183 consecutive AF patients who underwent initial ablation for AF were enrolled in this retrospective observational study. Serum cystatin C before ablation was measured, and the estimated glomerular filtration rate (eGFR) was calculated. LVA were defined as sites of left atrial electrogram amplitude <0.5 mV. Of 183 patients, 76 (42%) had LVA. Patients with LVA had lower eGFR calculated using cystatin C (74±22 vs. 86±24 mL/min/1.73 m2, P=0.001). The optimal cut-off of the calculated eGFR was 71.5 mL/min/1.73 m2, corresponding to a 79.4% sensitivity, 50% specificity, and 67.2% predictive accuracy. LVA occurred more frequently in patients with more severe categories of CKD. On multivariate analysis, eGFR <71.5 mL/min/1.73 m2was an independent predictor of LVA (odds ratio, 3.3; 95% CI: 1.4-7.8; P=0.006).
CONCLUSIONS: CKD severity was correlated with left atrial LVA prevalence in patients with AF undergoing catheter ablation.

Entities:  

Keywords:  Atrial fibrillation; Low-voltage area; Renal dysfunction; Substrate

Mesh:

Substances:

Year:  2019        PMID: 30853681     DOI: 10.1253/circj.CJ-18-1277

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Responsiveness to bepridil predicts atrial substrate in patients with persistent atrial fibrillation.

Authors:  Daisuke Yakabe; Yusuke Fukuyama; Masahiro Araki; Toshihiro Nakamura
Journal:  J Arrhythm       Date:  2021-01-04

2.  Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score.

Authors:  Timm Seewöster; Petra Büttner; Samira Zeynalova; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2020-05-27       Impact factor: 2.882

3.  Predictors of the voltage derived left atrial fibrosis in patients with long-standing persistent atrial fibrillation.

Authors:  Radoslaw M Kiedrowicz; Maciej Wielusinski; Andrzej Wojtarowicz; Jaroslaw Kazmierczak
Journal:  Cardiol J       Date:  2020-05-18       Impact factor: 3.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.